Bulletin physiology and pathology of respiration,
Journal Year:
2023,
Volume and Issue:
89, P. 79 - 87
Published: Sept. 28, 2023
Introduction.
Currently,
there
is
a
separate
phenotype
“bronchial
asthma
–
obesity”,
manifested
by
more
severe
course
of
the
disease,
low
rates
achieving
control,
resistance
to
basic
therapy.
Asthma,
like
obesity,
recognized
as
classic
example
multifactorial
diseases,
which
are
based
on
rather
complex
gene
network.
The
active
search
for
genetic
markers
characterizing
individual
characteristics
human
metabolism
continues.
Of
particular
interest
genes
involved
in
regulation
fat
and
carbohydrate
metabolism.
Aim.
Analysis
associations
polymorphic
loci
Ala54Thr
(G163A)
FABP2
with
bronchial
varying
severity
control
children.
Materials
methods.
161
children
remission
were
examined
continuous
sampling
method,
59
patients
obesity
1-3
degrees
without
concomitant
endocrine
pathology.
examination
included
general
clinical,
functional,
instrumental
level
was
determined
according
GINA
criteria
(2018).
biochemical
study
carried
out
an
automatic
analyzer
SAPPHIRE
400
(Japan).
polymorphisms
real-time
polymerase
chain
reaction
using
sets
“Metabolism”
(Research
Production
Company
“Litekh”,
Moscow)
CFX-96
Biorat
device
(USA).
Results.
We
have
not
identified
presence
obesity.
It
that
asthma,
frequency
carrying
homozygous
genotype
Thr/Thr
minor
allele
Thr
increased
1.5
times
compared
group
(OR
9.043;
95%CI
[2,093–39,073],
p=0.0011
OR
2.946;
[1,698‒5,111],
p=0.001,
respectively),
carriage
rare
A
risk
uncontrolled
2.42;
[1.23‒4.79],
p=0.03
1.75;
[1,119‒2,736],
p=0.01),
Ala/Ala
frequent
Ala
detected
often
associated
2.176;
[1.001‒4.727],
p=0.0008
2.378;
[1.495‒3.780],
p=0.0002,
respectively).
Conclusion.
Although
we
it
has
been
shown
Ala54Thr+Thr54Тhr
genotypes
significantly
higher
glucose
levels
(4.9±0.06
mmol/L
carriers
Ala54Ala
4.0±0.06
mmol/L,
p<0.001),
cholesterol
(4.8±0.4
3.93±0.1
p<0.05)
density
lipoproteins
(2.55±0.09
2.26±0.1
p<0.05).
There
obvious
need
further
investigation
effect
polymorphism
indicators
lipid
metabolism,
depending
nature
diets.
These
issues
require
part
probable
cause-and-effect
relationships
creation
personalized
programs
variants.
Frontiers in Molecular Biosciences,
Journal Year:
2025,
Volume and Issue:
12
Published: Feb. 26, 2025
Background
Numerous
studies
have
reported
that
dysregulation
of
fatty
acid
metabolic
pathways
is
associated
with
the
pathogenesis
vitiligo,
in
which
arachidonic
metabolism
(AAM)
plays
an
important
role.
However,
molecular
mechanisms
AAM
vitiligo
not
been
clarified.
Therefore,
we
aimed
to
identify
biomarkers
and
using
bioinformatics
methods.
Methods
The
GSE75819
GSE65127
datasets
were
used
this
study
as
training
validation
sets,
respectively,
along
58
AAM-related
genes
(AAM-RGs).
differentially
expressed
(DEGs)
between
lesional
control
groups
set
identified
through
differential
expression
analysis.
A
biomarker-based
nomogram
was
constructed
predict
risk
vitiligo.
Results
15
overlapping
candidate
obtained
DEGs
AAM-RGs.
Machine-learning
algorithms
six
key
PTGDS
,
PNPLA8
FAAH
ABHD12
PTGS1
MGLL
.
In
both
regarded
biomarkers.
based
on
these
showed
potential
for
predicting
Functional
enrichment,
immune
cell
infiltration,
regulatory
network
analyses
elucidate
mechanisms.
Conclusion
conclusion,
implicated
influence
These
findings
offer
insights
into
treatment,
although
further
research
needed
a
comprehensive
understanding.
Nutrients,
Journal Year:
2025,
Volume and Issue:
17(6), P. 1089 - 1089
Published: March 20, 2025
Objectives:
The
objective
of
this
study
is
to
outline
a
framework
for
how
fatty
acids
may
be
acting
as
mediators/suppressors
and/or
moderators
an
individual’s
genetic
predisposition
cardiovascular
lipid
biomarkers.
Methods:
All
UK
Biobank
participants
with
demographic
and
lifestyle
variables,
circulating
lipids,
NMR-measured
acid
data
collected
at
the
baseline
visit
(N
=
229,859)
were
included
in
analyses.
We
fit
four
separate
linear
regression
models,
one
each
following
common
measures
lipids:
total
cholesterol,
HDL-c,
LDL-c,
triglycerides.
Each
model
predicted
lipids
by
FADS
(a
well-known
desaturase
gene
complex)
haplotype,
addition
individual
ω-3
(DHA,
non-DHA,
total),
ω-6
(LA,
non-LA,
or
SFA
factors
additive
(mediation/suppression)
using
interaction
term
(with
FADS)
(moderation).
models
adjusted
wide
range
medical
history
variables
evaluated
against
Bonferroni-adjusted
significance
level
(p
<
8.9
×
10−4).
Results:
Across
56
(four
seven
FAs
two
conceptual
(mediation/suppression
moderation)),
we
found
evidence
19
moderation,
12
mediation,
16
suppression
effects
FADS–lipid
relationship.
For
example,
adjusting
DHA
levels
mediator,
association
genotype
HDL-c
substantially
lessened
both
minor
genotypes
reflecting
>122%
mediation
DHA.
Additionally,
that
LDL-c
moderated,
some
extent,
all
measures.
Conclusions:
This
analysis
demonstrates
profile
can
act
mediator/suppressor
moderator
various
Future
work
necessary
expand
cross-sectional
examination
determine
directionality
temporality
moderation
presented.
research
has
been
conducted
Resource
under
Application
Number
85092.
American Journal of Clinical Nutrition,
Journal Year:
2024,
Volume and Issue:
120(4), P. 794 - 803
Published: Aug. 10, 2024
Avocado
intake
improves
dietary
fat
quality,
but
the
subsequent
impact
on
red
blood
cell
(RBC)
saturated
(SFA),
monounsaturated
(MUFA),
polyunsaturated
(PUFA),
and
trans-fatty
acid
(TFA)
composition
association
with
cardiometabolic
health,
has
not
been
elucidated.
To
compare
effect
of
consuming
1
avocado/d
relative
to
habitual
diet
(HAB)
RBC-FA
profiles,
their
visceral
adiposity
risk
factors
(CMRFs)
in
individuals
abdominal
obesity.
profiling
at
baseline,
3-
6
mo
was
conducted
participants
(n
=
994)
from
Habitual
Diet
Trial
(HAT).
HAT
a
multisite,
free-living,
parallel-arm
intervention
study
which
were
randomly
assigned
either
avocado-supplemented
group
(AVO,
usual
avocado/d)
or
HAB
(usual
limited
avocado
intake)
for
mo.
Changes
secondary
outcome
measure,
determined
within
between
groups
using
linear
regression
mixed
models,
adjusting
age,
sex,
BMI,
clinical
site,
smoking
status,
percentage
energy
baseline.
The
changes
RBC-FAs
CMRFs
assessed
after
covariate
FDR
(<0.05)
adjustment.
No
major
differences
profiles
observed
groups,
exception
MUFA
cis-vaccenic
[18:1n−7c],
significantly
higher
AVO
(β:
0.11
[0.05,
0.17])
compared
0.03
[−0.03,
0.08])
participants.
In
group,
increases
cis
(18:1n−7c,
oleic
[18;1n−9c],
erucic
[22:1n−9c])
trans
(palmitelaidic
[16:1n−7t],
vaccenic
[18:1n−7t],
elaidic
[18:1n−9t],
petroselaidic
[18;1n−10-12t),
as
well
PUFA
γ-linolenic
[18:3n−6],
dihomo-γ-linolenic
[20:3n−6],
arachidonic
[20:4n−6],
α-linolenic
[18:3n−3]
associated
unfavorable
measures,
lipid
glucose,
insulin
high
sensitivity
C-reactive
protein
concentrations.
Daily
over
6-mo
modified
RBC–MUFA
composition,
notably
18:1n−7c,
potentially
mitigated
some
individual
RBC-FA–CMRF
associations
time
group.
This
trial
registered
https://clinicaltrials.gov/study
NCT03528031.
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(22), P. 3937 - 3937
Published: Nov. 18, 2024
Polyunsaturated
fatty
acids
(PUFAs)
are
not
only
structural
components
of
membrane
phospholipids
and
energy
storage
molecules
in
cells.
PUFAs
important
factors
that
regulate
various
biological
functions,
including
inflammation,
oxidation,
immunity.
Both
CHILD`S HEALTH,
Journal Year:
2024,
Volume and Issue:
19(3), P. 162 - 174
Published: May 26, 2024
The
literature
review
highlights
the
issue
of
genetic
risk
factors
associated
with
development
metabolic
dysfunction-associated
fatty
liver
disease.
Human
examinations
revealed
132
genes
among
which
32
loci
are
strongly
pathogenesis
It
has
been
found
that
developing
disease
is
carried
by
single-nucleotide
variants
various
whose
products
involved
in
lipid
and
carbohydrate
metabolism,
maintenance
redox
state,
inflammation
fibrosis
tissue,
components
reactome.
authors
presented
a
detailed
list
singling
out
those
influence
directly
steatohepatitis
fibrosis.
Also,
they
emphasized
it
protein
3
containing
patatin-like
phospholipase
domain,
transmembrane
6
superfamily
member
2,
17b-hydroxysteroid
dehydrogenase
type
13
characterized
highest
degree
association
(odds
ratio
>
1.6)
compared
to
other
identified
gene
studies.
combination
several
polymorphisms
increases
severity
additive
steatogenic
effect
domain
2
probably
due
an
increased
expression
de
novo
lipogenesis.
emphasize
need
for
assessment
disease,
should
include
molecular
testing
at
early
stage
examination.
Saturated
fats
are
widely
seen
as
undesirable
components
of
a
healthy
diet,
result
their
illusive
association
with
elevated
serum
cholesterol.
The
regulation
cholesterol
is
now
better
understood
and
polyunsaturated
fatty
acids
rather
than
saturated
responsible.
Palmitic
acid
received
further
specious
allegations
inciting
inflammation
when
in
fact
it
was
found
to
play
an
auxiliary
role
precursor
ceramide
biosynthesis.
Studies
arthritic
lab
animals
showed
dietary
anti-inflammatory,
whereas
oils
pro-inflammatory.
Inflammation
plays
numerous
metabolic
diseases,
including
insulin
resistance,
liver
disease
syndrome
among
others.
Fat,
triglycerides
adipose
tissue,
efficient
way
for
living
organisms
store
energy
reduce
toxicity
other
macronutrients.
However,
tissue
lipolysis
releases
into
the
blood
provide
many
organs
supply
spare
glucose
brain
tissue.
Some
disorders
nonesterified
blood,
leading
hepatic
lipid
accumulation,
resistance.
This
paper
will
attempt
clarify
acids,
palmitic
particular,
regard
certain
adverse
health
conditions.
Dietetics,
Journal Year:
2024,
Volume and Issue:
3(4), P. 452 - 462
Published: Oct. 29, 2024
Saturated
fats
are
widely
seen
as
undesirable
components
of
a
healthy
diet,
result
their
illusory
association
with
elevated
serum
cholesterol.
The
regulation
cholesterol
is
now
better
understood
and
lack
polyunsaturated
fatty
acids,
rather
than
an
abundance
saturated
responsible.
Palmitic
acid
was
shown
to
incite
inflammation
at
unnaturally
high
concentrations
in
tissue
culture,
but
later
found
play
auxiliary
role
precursor
ceramide
biosynthesis
possibly
the
palmitoylation
membrane
receptors
involved
initiation
inflammation.
Studies
arthritic
lab
animals
showed
that
dietary
anti-inflammatory,
whereas
oils
pro-inflammatory.
Inflammation
plays
numerous
metabolic
diseases,
including
insulin
resistance,
liver
disease
syndrome,
among
others.
Fat,
triglycerides
adipose
tissue,
efficient
way
for
living
organisms
store
energy
reduce
toxicity
other
macronutrients.
Macronutrients,
such
excess
carbohydrates
converted
monounsaturated
acids
storage
tissue.
Fatty
released
from
during
fasting
some
disorders,
where
levels
nonesterified
blood
can
lead
hepatic
lipid
accumulation,
resistance.
Although
most
may
be
they
not
necessarily
derived
diet.
This
paper
will
attempt
clarify
palmitic
particular,
regard
certain
adverse
health
conditions.
Doctor Ru,
Journal Year:
2024,
Volume and Issue:
23(4), P. 27 - 31
Published: Jan. 1, 2024
Aim.
Based
on
current
literature
data,
to
evaluate
the
association
between
non-alcoholic
fatty
liver
disease
(NAFLD)
and
cardiovascular
diseases
(CVD),
consider
pathophysiological
mechanisms
underlying
this
relationship,
indicate
methods
for
reducing
cardiometabolic
risk
in
patients
with
NAFLD.
Key
points.
NAFLD
occupies
a
leading
position
structure
of
chronic
diseases,
is
one
manifestations
metabolic
syndrome
closely
associated
CVD.
The
relationship
prevalence
CVD
has
been
established
numerous
studies.
significantly
more
severe
A
number
meta-analyses
have
documented
direct
mortality.
Many
development
these
two
coincide.
Some
molecular
changes
that
play
an
important
role
are
also
involved
formation
Patients
often
atherosclerosis,
which
underlies
Conclusion.
All
modern
international
Russian
recommendations
management
pay
significant
attention
advisability
screening
need
reduce
through
lifestyle
modification
(optimizing
diet,
weight
loss,
increasing
physical
activity),
using
statin
medications,
ursodeoxycholic
acid
ademetionine.
Keywords:
disease,
steatosis,
steatohepatitis,
prevalence,
factors.